JP2013542955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542955A5 JP2013542955A5 JP2013537733A JP2013537733A JP2013542955A5 JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5 JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- compound
- hcv
- compound according
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40898910P | 2010-11-01 | 2010-11-01 | |
| US61/408,989 | 2010-11-01 | ||
| PCT/US2011/058404 WO2012061248A2 (en) | 2010-11-01 | 2011-10-28 | Novel specific hcv ns3 protease inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542955A JP2013542955A (ja) | 2013-11-28 |
| JP2013542955A5 true JP2013542955A5 (https=) | 2015-02-12 |
| JP5828903B2 JP5828903B2 (ja) | 2015-12-09 |
Family
ID=46025037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537733A Expired - Fee Related JP5828903B2 (ja) | 2010-11-01 | 2011-10-28 | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8729014B2 (https=) |
| EP (1) | EP2635570B1 (https=) |
| JP (1) | JP5828903B2 (https=) |
| CN (1) | CN103328466B (https=) |
| AU (1) | AU2011323658A1 (https=) |
| BR (1) | BR112013010836A2 (https=) |
| CA (1) | CA2815855C (https=) |
| IL (1) | IL225908A0 (https=) |
| MX (1) | MX2013004906A (https=) |
| WO (1) | WO2012061248A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013529627A (ja) | 2010-06-24 | 2013-07-22 | パンメド リミテッド | ヒドロキシクロロキンまたはヒドロキシクロロキンおよび抗ウイルス剤の組合せを使用するｃ型肝炎ウイルス関連疾患の処置 |
| MX2013004906A (es) | 2010-11-01 | 2013-12-06 | Genoscience Pharma | Nuevos inhibidores especificos de la proteasa ns3 de hcv. |
| WO2012176149A1 (en) | 2011-06-23 | 2012-12-27 | Panmed Ltd. | Treatment of hepatitis c virus |
| US9040479B2 (en) | 2012-01-12 | 2015-05-26 | Cocrystal Pharma, Inc. | HCV NS3 protease inhibitors |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| WO2014145095A1 (en) | 2013-03-15 | 2014-09-18 | Gilead Sciences, Inc. | Macrocyclic and bicyclic inhibitors of hepatitis c virus |
| BR112016023833A2 (pt) * | 2014-04-15 | 2017-10-10 | Cocrystal Pharma Inc | compostos, composições, métodos e uso para tratar ou prevenir infecções por vírus da hepatite c |
| CN105315261A (zh) * | 2014-08-04 | 2016-02-10 | 正大天晴药业集团股份有限公司 | Hcv ns3蛋白酶抑制剂的钠盐 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000536A1 (en) | 1993-06-22 | 1995-01-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds |
| KR100509388B1 (ko) | 1996-10-18 | 2005-08-23 | 버텍스 파마슈티칼스 인코포레이티드 | 세린 프로테아제, 특히 간염 ｃ 바이러스 ｎｓ３ 프로테아제의 저해제 |
| US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
| ES2240446T3 (es) | 2000-04-03 | 2005-10-16 | Vertex Pharma | Inhibidores de serina proteasas, particularmente la proteasa ns3 del virus de la hepatitis c. |
| AU2002331064B2 (en) | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| WO2004032827A2 (en) | 2002-05-20 | 2004-04-22 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| BRPI0412502A (pt) | 2003-07-10 | 2006-09-19 | Achillion Pharmaceuticals Inc | derivados de ariltiouréia substituìda úteis como inibidores de replicação viral |
| JP4902361B2 (ja) | 2004-01-30 | 2012-03-21 | メディヴィル・アクチエボラーグ | Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター |
| ES2328596T3 (es) | 2004-05-20 | 2009-11-16 | Schering Corporation | Prolinas sustituidas como inhibidores de la serina proteasa del virus ns3 de la hepatitis c. |
| US7323447B2 (en) * | 2005-02-08 | 2008-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2006111906A2 (en) | 2005-04-19 | 2006-10-26 | Philips Intellectual Property & Standards Gmbh | Illumination system comprising a red-emitting ceramic luminescence converter |
| TWI387603B (zh) | 2005-07-20 | 2013-03-01 | Merck Sharp & Dohme | Ｈｃｖ ｎｓ３蛋白酶抑制劑 |
| BRPI0614205A2 (pt) | 2005-08-01 | 2016-11-22 | Merck & Co Inc | composto, composição farmacêutica, e, uso de composto |
| EP2029153A2 (en) | 2006-01-27 | 2009-03-04 | Phenomix Corporation | Hepatitis c serine protease inhibitors and uses therefor |
| KR20090024834A (ko) * | 2006-07-05 | 2009-03-09 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규 억제제 |
| CN101495457A (zh) * | 2006-07-05 | 2009-07-29 | 因特蒙公司 | C型肝炎病毒复制的新颖抑制剂 |
| US7635683B2 (en) | 2006-08-04 | 2009-12-22 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| CN101553170B (zh) | 2006-11-24 | 2011-11-09 | 株式会社岛津制作所 | X射线透视摄影装置 |
| WO2008134397A1 (en) | 2007-04-26 | 2008-11-06 | Enanta Pharmaceuticals, Inc. | Aza-tripeptide hepatitis c serine protease inhibitors |
| MX2010006210A (es) | 2007-12-05 | 2010-08-10 | Enanta Pharm Inc | Inhibidores de serina proteasa de hcv de tripeptido fluorado. |
| US8293705B2 (en) * | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
| CA2710144A1 (en) | 2007-12-21 | 2009-07-02 | Avila Therapeutics, Inc. | Hcv protease inhibitors and uses thereof |
| EA201071034A1 (ru) | 2008-04-15 | 2011-06-30 | Интермьюн, Инк. | Новые макроциклические ингибиторы репликаций вируса гепатита с |
| AU2011209051B2 (en) * | 2010-01-27 | 2015-01-15 | AB Pharma Ltd. | Polyheterocyclic compounds highly potent as HCV inhibitors |
| MX2013004906A (es) | 2010-11-01 | 2013-12-06 | Genoscience Pharma | Nuevos inhibidores especificos de la proteasa ns3 de hcv. |
-
2011
- 2011-10-28 MX MX2013004906A patent/MX2013004906A/es active IP Right Grant
- 2011-10-28 BR BR112013010836A patent/BR112013010836A2/pt not_active IP Right Cessation
- 2011-10-28 US US13/284,641 patent/US8729014B2/en not_active Expired - Fee Related
- 2011-10-28 CA CA2815855A patent/CA2815855C/en not_active Expired - Fee Related
- 2011-10-28 EP EP11838590.5A patent/EP2635570B1/en not_active Not-in-force
- 2011-10-28 JP JP2013537733A patent/JP5828903B2/ja not_active Expired - Fee Related
- 2011-10-28 AU AU2011323658A patent/AU2011323658A1/en not_active Abandoned
- 2011-10-28 WO PCT/US2011/058404 patent/WO2012061248A2/en not_active Ceased
- 2011-10-28 CN CN201180063866.1A patent/CN103328466B/zh not_active Expired - Fee Related
-
2013
- 2013-04-23 IL IL225908A patent/IL225908A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542955A5 (https=) | ||
| JP2012528161A5 (https=) | ||
| JP2011528713A5 (https=) | ||
| JP2013510120A5 (https=) | ||
| JP2009504763A5 (https=) | ||
| JP2011079828A5 (https=) | ||
| JP2012504126A5 (https=) | ||
| JP2019526596A5 (https=) | ||
| JP2014504643A5 (https=) | ||
| JP2008530096A5 (https=) | ||
| JP2007535491A5 (https=) | ||
| EP2341065A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4a protease | |
| JP2005524632A5 (https=) | ||
| RU2015114543A (ru) | Способы лечения гепатита с | |
| JP2011520906A5 (https=) | ||
| JP2011515398A5 (https=) | ||
| JP2010509359A5 (https=) | ||
| JP2012504132A5 (https=) | ||
| JP2010510233A5 (https=) | ||
| JP2012516871A5 (https=) | ||
| JP2012512169A5 (https=) | ||
| TN2012000009A1 (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
| JP2014508804A5 (https=) | ||
| JP2012504632A5 (https=) | ||
| JP2016040288A5 (https=) |